
Development of a robust luciferase reporter 1b/2a hepatitis C virus (HCV) for characterization of early stage HCV life cycle inhibitors
Keywords: ADAR1, adenosine deaminases acting on RNA; DMEM, Dulbecco’s modified Eagle medium; EC50, 50% effective concentration; FMDV, foot and mouth disease virus; GAPDH, glutaraldehyde-3-phosphate dehydrogenase; HCV, hepatitis C virus; HCVcc, hepatitis C virus in